BIOA (NASDAQ: BIOA) insider files Form 144 showing multiple sales

Rhea-AI Filing Summary

Paul Rubin reported multiple sales of common stock on Form 144. The filings list sales including 68,897 shares on 12/04/2025, 18,000 shares on 12/09/2025, 7,433 shares on 01/02/2026, and 7,433 shares on 02/02/2026. The notices identify Fidelity Brokerage Services LLC as a broker on 03/02/2026 for additional option-related sales.

Insights

Securities Compliance Analyst

Form 144 filings document reported insider dispositions by Paul Rubin; no material corporate action is disclosed.

These entries record open-market or broker-mediated sales of common stock by an individual, with specific share counts and trade dates: 68,897, 18,000, and two transactions of 7,433 shares. The filings name Fidelity Brokerage Services LLC in connection with sales noted on 03/02/2026.

Because these are routine resale notices, their investment impact depends on trading context and timing; filings show transaction dates and quantities but do not state proceeds recipients beyond the selling holder.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7433	148882.99	35855037	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Option Granted 07/01/2020	Issuer			5433	03/02/2026	Cash
Common	03/02/2026	Option Granted 05/29/2022	Issuer			2000	03/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Paul Rubin 5885 Hollis St Suite 370 Emeryville CA 94608	Common	12/04/2025	68897	701911.75
Paul Rubin 5885 Hollis St Suite 370 Emeryville CA 94608	Common	12/09/2025	18000	216000.00
Paul Rubin 5885 Hollis St Suite 370 Emeryville CA 94608	Common	01/02/2026	7433	95490.42
Paul Rubin 5885 Hollis St Suite 370 Emeryville CA 94608	Common	02/02/2026	7433	139368.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What share sales did Paul Rubin report for BIOA?

Paul Rubin reported sales of 68,897; 18,000; 7,433; and 7,433 shares on listed dates. The Form 144 entries show trade dates of 12/04/2025, 12/09/2025, 01/02/2026, and 02/02/2026, and include broker identification for related transactions filed on 03/02/2026.

Which broker is named in the BIOA Form 144 filings?

Fidelity Brokerage Services LLC is identified as the broker. The filings list Fidelity at an address in Smithfield, RI and reference broker-related entries dated 03/02/2026 for option-exercise or cash-sale transactions.

Do the Form 144 entries state the sale proceeds for BIOA transactions?

The filings include per-transaction dollar amounts alongside share counts for some trades. Examples in the excerpt show amounts such as $701,911.75, $216,000.00, $95,490.42, and $139,368.75 tied to the listed sale dates.

Are the transactions in the BIOA excerpt open-market sales or option exercises?

The excerpt includes both resale entries and references to options granted on prior dates. It lists ‘‘Option Granted 07/01/2020’’ and ‘‘Option Granted 05/29/2022’’ alongside cash sales and broker entries dated 03/02/2026.

Does the Form 144 show total shares outstanding or company-level changes for BIOA?

The excerpt contains large numeric fields but does not present a company-level action. The entries focus on specific resale transactions by the reporting person and broker notations rather than corporate amendments or capital changes.